Leukeran (generic name Chlorambucil) is used alone or with other antineoplastics to treat chronic lymphocytic leukemia, malignant lymphomas, Hodgkin's disease, giant follicular lymphoma, and cancers of the ovaries, breast, and testes. Unlabled uses include treatment of nonneoplastic conditions such as vasculitis complicating rheumatoid arthritis, autoimmune hemolytic anemias associated with cold agglutinins, lupus glomerulonephritis, idiopathic nephrotic syndrome, polycythenmia vera, and macroglobulinemia.
Copyright is owned by the author of this work.
Hunt, Leslie R., "Leukeran" (2014). Natural Sciences Poster Sessions. 59.